<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Probenecid</id>
	<title>Probenecid - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Probenecid"/>
	<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Probenecid&amp;action=history"/>
	<updated>2026-04-20T13:00:43Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.38.2</generator>
	<entry>
		<id>https://wikem.org/w/index.php?title=Probenecid&amp;diff=385471&amp;oldid=prev</id>
		<title>Ostermayer at 00:23, 28 January 2026</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Probenecid&amp;diff=385471&amp;oldid=prev"/>
		<updated>2026-01-28T00:23:36Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 00:23, 28 January 2026&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l7&quot;&gt;Line 7:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 7:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Adult Dosing==&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Adult Dosing==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;===General===&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-added&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;*Determine indication (Gout vs Adjuvant)&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-added&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;===Hyperuricemia ([[Gout]])===&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;===Hyperuricemia ([[Gout]])===&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l20&quot;&gt;Line 20:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 18:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Given concurrently with [[Cefoxitin]] 2g IM x 1&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Given concurrently with [[Cefoxitin]] 2g IM x 1&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;===Neurosyphilis (Adjunct)===&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;===&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;[[&lt;/ins&gt;Neurosyphilis&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;]] &lt;/ins&gt;(Adjunct)===&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*500mg PO q6h  &lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*500mg PO q6h  &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Given concurrently with Procaine [[Penicillin]] G 2.4 million units IM daily x 10-14 days&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Given concurrently with Procaine [[Penicillin]] G 2.4 million units IM daily x 10-14 days&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Ostermayer</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Probenecid&amp;diff=385442&amp;oldid=prev</id>
		<title>Ostermayer: Created page with &quot;==General== *Type: Is DrugClass::Uricosuric Agent Is DrugClass::Antibiotic Adjuvant *Dosage Forms: Tablet *Dosage Strengths: 500mg *Routes of Administration: PO *Common Trade Names: Benemid, Probalan  ==Adult Dosing== ===General=== *Determine indication (Gout vs Adjuvant)  ===Hyperuricemia (Gout)=== *Start: 250mg PO bid x 1 week *Maintenance: 500mg PO bid *May increase by 500mg/day q4weeks if not controlled *Max: 2g/day  ===Pelvic Inflammatory Disease (PID)...&quot;</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Probenecid&amp;diff=385442&amp;oldid=prev"/>
		<updated>2026-01-27T18:03:45Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;==General== *Type: &lt;a href=&quot;/w/index.php?title=Is_DrugClass::Uricosuric_Agent&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;Is DrugClass::Uricosuric Agent (page does not exist)&quot;&gt;Is DrugClass::Uricosuric Agent&lt;/a&gt; &lt;a href=&quot;/w/index.php?title=Is_DrugClass::Antibiotic_Adjuvant&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;Is DrugClass::Antibiotic Adjuvant (page does not exist)&quot;&gt;Is DrugClass::Antibiotic Adjuvant&lt;/a&gt; *Dosage Forms: Tablet *Dosage Strengths: 500mg *Routes of Administration: PO *Common Trade Names: Benemid, Probalan  ==Adult Dosing== ===General=== *Determine indication (Gout vs Adjuvant)  ===Hyperuricemia (&lt;a href=&quot;/wiki/Gout&quot; class=&quot;mw-redirect&quot; title=&quot;Gout&quot;&gt;Gout&lt;/a&gt;)=== *Start: 250mg PO bid x 1 week *Maintenance: 500mg PO bid *May increase by 500mg/day q4weeks if not controlled *Max: 2g/day  ===Pelvic Inflammatory Disease (PID)...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;==General==&lt;br /&gt;
*Type: [[Is DrugClass::Uricosuric Agent]] [[Is DrugClass::Antibiotic Adjuvant]]&lt;br /&gt;
*Dosage Forms: Tablet&lt;br /&gt;
*Dosage Strengths: 500mg&lt;br /&gt;
*Routes of Administration: PO&lt;br /&gt;
*Common Trade Names: Benemid, Probalan&lt;br /&gt;
&lt;br /&gt;
==Adult Dosing==&lt;br /&gt;
===General===&lt;br /&gt;
*Determine indication (Gout vs Adjuvant)&lt;br /&gt;
&lt;br /&gt;
===Hyperuricemia ([[Gout]])===&lt;br /&gt;
*Start: 250mg PO bid x 1 week&lt;br /&gt;
*Maintenance: 500mg PO bid&lt;br /&gt;
*May increase by 500mg/day q4weeks if not controlled&lt;br /&gt;
*Max: 2g/day&lt;br /&gt;
&lt;br /&gt;
===[[Pelvic Inflammatory Disease (PID)]]===&lt;br /&gt;
*1g PO x 1&lt;br /&gt;
*Given concurrently with [[Cefoxitin]] 2g IM x 1&lt;br /&gt;
&lt;br /&gt;
===Neurosyphilis (Adjunct)===&lt;br /&gt;
*500mg PO q6h &lt;br /&gt;
*Given concurrently with Procaine [[Penicillin]] G 2.4 million units IM daily x 10-14 days&lt;br /&gt;
&lt;br /&gt;
==Pediatric Dosing==&lt;br /&gt;
===General (&amp;lt; 2 years)===&lt;br /&gt;
*Contraindicated&lt;br /&gt;
&lt;br /&gt;
===General (2 - 14 years)===&lt;br /&gt;
*Adjunct to antibiotic therapy (limited data/use)&lt;br /&gt;
*Initial: 25mg/kg PO x 1&lt;br /&gt;
*Maintenance: 40mg/kg/day divided q6h&lt;br /&gt;
&lt;br /&gt;
==Special Populations==&lt;br /&gt;
*Pregnancy: B&lt;br /&gt;
*Lactation: Excreted in breast milk; safety not established&lt;br /&gt;
*Renal&lt;br /&gt;
**Adult&lt;br /&gt;
***CrCl &amp;lt;30: Avoid use (likely ineffective for uricosuric effect; may typically be used for simple antibiotic adjuvant effect if necessary, but risk of toxicity increases)&lt;br /&gt;
**Pediatric&lt;br /&gt;
***Not defined&lt;br /&gt;
*Hepatic&lt;br /&gt;
**No specific guidelines defined, but metabolized by liver&lt;br /&gt;
&lt;br /&gt;
==Contraindications==&lt;br /&gt;
*Allergy to Probenecid&lt;br /&gt;
*Children &amp;lt; 2 years of age&lt;br /&gt;
*Concomitant use with ketorolac (increases ketorolac plasma levels significantly)&lt;br /&gt;
*Concomitant use with salicylates (aspirin antagonizes uricosuric action)&lt;br /&gt;
*Uric acid lithiasis (kidney stones)&lt;br /&gt;
*Acute [[Gout]] attack (do not initiate therapy during acute attack)&lt;br /&gt;
*Blood dyscrasias&lt;br /&gt;
*[[G6PD Deficiency]] (risk of hemolytic anemia)&lt;br /&gt;
&lt;br /&gt;
==Adverse Reactions==&lt;br /&gt;
===Serious===&lt;br /&gt;
*[[Anaphylaxis]]&lt;br /&gt;
*Hemolytic [[Anemia]] (associated with G6PD deficiency)&lt;br /&gt;
*Aplastic Anemia&lt;br /&gt;
*Hepatic Necrosis&lt;br /&gt;
*Nephrotic Syndrome&lt;br /&gt;
*[[Seizures]]&lt;br /&gt;
&lt;br /&gt;
===Common===&lt;br /&gt;
*[[Headache]]&lt;br /&gt;
*[[Nausea and Vomiting]]&lt;br /&gt;
*Anorexia&lt;br /&gt;
*Dizziness&lt;br /&gt;
*Flushing&lt;br /&gt;
*[[Rash]] (Urticaria/Pruritus)&lt;br /&gt;
*Gingival soreness&lt;br /&gt;
*Urinary frequency&lt;br /&gt;
&lt;br /&gt;
==Pharmacology==&lt;br /&gt;
*Half-life: 3-8h (dose dependent)&lt;br /&gt;
*Metabolism: Liver&lt;br /&gt;
*Excretion: Urine&lt;br /&gt;
*Mechanism of Action:&lt;br /&gt;
**Uricosuric: Inhibits tubular reabsorption of urate, increasing urinary excretion of uric acid.&lt;br /&gt;
**Adjuvant: Inhibits renal tubular secretion of beta-lactam antibiotics (penicillins, cephalosporins), thereby increasing their plasma concentrations and half-life.&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[Gout]]&lt;br /&gt;
*[[Pelvic Inflammatory Disease (PID)]]&lt;br /&gt;
*[[Syphilis]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Pharmacology]] [[Category:ID]]&lt;/div&gt;</summary>
		<author><name>Ostermayer</name></author>
	</entry>
</feed>